Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6325061rdf:typepubmed:Citationlld:pubmed
pubmed-article:6325061lifeskim:mentionsumls-concept:C0206558lld:lifeskim
pubmed-article:6325061lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6325061lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:6325061lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:6325061lifeskim:mentionsumls-concept:C0006118lld:lifeskim
pubmed-article:6325061lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:6325061pubmed:issue2lld:pubmed
pubmed-article:6325061pubmed:dateCreated1984-6-14lld:pubmed
pubmed-article:6325061pubmed:abstractTextSixty-five patients underwent craniotomy for brain tumors; of these 35 had glioblastoma multiforme (GM). The GM cases, as a group, showed significantly higher serum titers for herpesvirus type 1 (HSV-1) neutralizing antibodies (NT) than the non-glioblastoma cases. Both the GM group and the pituitary adenoma group had high levels of HSV-1 serum antibodies with the enzyme-linked immunosorbent assay (ELISA). These data, combined with other evidence, lead us to speculate that HSV-1 infections may be associated with certain brain tumors in humans. However, coincidental causes for these elevated HSV-1 titers must be ruled out.lld:pubmed
pubmed-article:6325061pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6325061pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6325061pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6325061pubmed:languageenglld:pubmed
pubmed-article:6325061pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6325061pubmed:citationSubsetIMlld:pubmed
pubmed-article:6325061pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6325061pubmed:statusMEDLINElld:pubmed
pubmed-article:6325061pubmed:issn0722-5091lld:pubmed
pubmed-article:6325061pubmed:authorpubmed-author:YoungH FHFlld:pubmed
pubmed-article:6325061pubmed:authorpubmed-author:MurrayB KBKlld:pubmed
pubmed-article:6325061pubmed:authorpubmed-author:HadfieldM GMGlld:pubmed
pubmed-article:6325061pubmed:authorpubmed-author:ThomsonT ATAlld:pubmed
pubmed-article:6325061pubmed:issnTypePrintlld:pubmed
pubmed-article:6325061pubmed:volume3lld:pubmed
pubmed-article:6325061pubmed:ownerNLMlld:pubmed
pubmed-article:6325061pubmed:authorsCompleteYlld:pubmed
pubmed-article:6325061pubmed:pagination68-71lld:pubmed
pubmed-article:6325061pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:meshHeadingpubmed-meshheading:6325061-...lld:pubmed
pubmed-article:6325061pubmed:articleTitleHerpesvirus type 1 serum antibodies and brain tumors in humans.lld:pubmed
pubmed-article:6325061pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6325061pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6325061pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed